DK0853617T3 - 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinylderivater - Google Patents
2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinylderivaterInfo
- Publication number
- DK0853617T3 DK0853617T3 DK96929275T DK96929275T DK0853617T3 DK 0853617 T3 DK0853617 T3 DK 0853617T3 DK 96929275 T DK96929275 T DK 96929275T DK 96929275 T DK96929275 T DK 96929275T DK 0853617 T3 DK0853617 T3 DK 0853617T3
- Authority
- DK
- Denmark
- Prior art keywords
- dioxo
- tetrahydro
- quinoxalinyl derivatives
- quinoxalinyl
- derivatives
- Prior art date
Links
- -1 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinyl Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH247995 | 1995-08-31 | ||
| CH273495 | 1995-09-27 | ||
| CH274795 | 1995-09-28 | ||
| CH121396 | 1996-05-10 | ||
| CH163096 | 1996-06-28 | ||
| PCT/EP1996/003644 WO1997008155A1 (en) | 1995-08-31 | 1996-08-19 | Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0853617T3 true DK0853617T3 (da) | 2004-07-05 |
Family
ID=27508939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96929275T DK0853617T3 (da) | 1995-08-31 | 1996-08-19 | 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinylderivater |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6080743A (da) |
| EP (1) | EP0853617B1 (da) |
| JP (1) | JP3159711B2 (da) |
| KR (1) | KR100462337B1 (da) |
| CN (1) | CN1137886C (da) |
| AR (1) | AR005229A1 (da) |
| AT (1) | ATE260902T1 (da) |
| AU (1) | AU705871B2 (da) |
| BR (1) | BRPI9603626B8 (da) |
| CA (1) | CA2227851C (da) |
| CZ (1) | CZ56298A3 (da) |
| DE (1) | DE69631774T2 (da) |
| DK (1) | DK0853617T3 (da) |
| ES (1) | ES2217324T3 (da) |
| HK (1) | HK1010196A1 (da) |
| HU (1) | HUP9801676A3 (da) |
| IL (1) | IL122987A (da) |
| MY (1) | MY132385A (da) |
| NO (1) | NO310236B1 (da) |
| NZ (1) | NZ316497A (da) |
| PL (1) | PL189637B1 (da) |
| PT (1) | PT853617E (da) |
| SI (1) | SI0853617T1 (da) |
| SK (1) | SK25298A3 (da) |
| TR (1) | TR199800349T2 (da) |
| WO (1) | WO1997008155A1 (da) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6191134B1 (en) * | 1996-06-05 | 2001-02-20 | Warner-Lambert Company | Amide derivatives of substituted quinoxaline 2, 3-diones as glutamate receptor antagonists |
| IL129394A (en) * | 1996-10-24 | 2002-05-23 | Novartis Ag | Amino-alkaline phosphonic acids are converted |
| WO1998023599A1 (en) * | 1996-11-25 | 1998-06-04 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
| US6172065B1 (en) * | 1997-03-04 | 2001-01-09 | Warner-Lambert Company | Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US6340758B1 (en) | 1997-05-16 | 2002-01-22 | Warner-Lambert Company | Conformationally semi-constrained quinoxaline 2,3-diones as neuroprotective agents |
| US6096744A (en) * | 1998-05-04 | 2000-08-01 | Warner-Lambert Company | Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| US7361666B2 (en) | 1999-05-25 | 2008-04-22 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6677332B1 (en) | 1999-05-25 | 2004-01-13 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6635661B2 (en) | 2000-05-25 | 2003-10-21 | Sepracor Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| AU2001216218A1 (en) | 2000-05-25 | 2001-12-11 | Sepracor, Inc. | Heterocyclic analgesic compounds and method of use thereof |
| EP1436258A4 (en) * | 2001-03-08 | 2005-03-23 | Univ Emory | ANTAGONISTS OF THE NMDA RECEPTOR DEPENDENT OF PH |
| TW200403066A (en) * | 2002-04-30 | 2004-03-01 | Novartis Ag | New uses of substituted aminoalkanephosphonic acids |
| GB0310868D0 (en) * | 2003-05-12 | 2003-06-18 | Novartis Ag | Organic compounds |
| US7524837B2 (en) * | 2003-05-12 | 2009-04-28 | Janssen Pharmaceutica N.V. | Benzotriazapinone salts and methods for using same |
| EP1670774A1 (en) * | 2003-09-30 | 2006-06-21 | Janssen Pharmaceutica N.V. | Quinoxaline compounds |
| US20060020029A1 (en) * | 2004-07-02 | 2006-01-26 | Shimasaki Craig D | Pharmaceutical compositions from ethnobotanicals |
| UA95788C2 (en) * | 2005-12-15 | 2011-09-12 | Ф. Хоффманн-Ля Рош Аг | Fused pyrrole derivatives |
| CN101815518B (zh) * | 2007-06-29 | 2013-01-09 | 埃莫里大学 | 用于神经保护的nmda受体拮抗剂 |
| EP2571865A1 (en) | 2010-05-20 | 2013-03-27 | Novartis AG | 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| US9737531B2 (en) | 2012-07-12 | 2017-08-22 | Glytech, Llc | Composition and method for treatment of depression and psychosis in humans |
| JO3225B1 (ar) * | 2012-11-27 | 2018-03-08 | Lilly Co Eli | 6-((s)-1-{1-[5-(2-هيدروكسي-إيثوكسي)-بيريدين-2-يل]-1h-بيرازول-3-يل}إيثيل)-3h-1 ، 3-بنزو ثيازول-2- أون باعتباره مضاد مستقبل ampa يعتمد على tarp- جاما 8 |
| CN103435561B (zh) * | 2013-08-19 | 2016-08-10 | 上海交通大学 | 一种新型d-氨基酸氧化酶抑制剂及其制备和应用 |
| KR20190112292A (ko) * | 2017-01-27 | 2019-10-04 | 장피트 | 자가 면역 질환을 치료하기 위한 ror-감마 조절 인자로서의 n-｛[2-(피페리딘-1-일)페닐](페닐)메틸｝-2-(3-옥소-3,4-디하이드로-2h-1,4-벤족사진-7-일)아세트아미드 유도체 및 관련 화합물 |
| AU2018284335A1 (en) | 2017-06-12 | 2020-01-30 | Glytech Llc. | Treatment of depression with NMDA antagonists and D2/5HT2A or selective 5HT2A antagonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156734A (en) * | 1976-02-13 | 1979-05-29 | Merck & Co., Inc. | Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid |
| CA2002864C (en) * | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
| EP0484437A4 (en) * | 1989-07-27 | 1994-06-01 | Searle & Co | Renal-selective prodrugs for the treatment of hypertension |
| US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| GB9418443D0 (en) * | 1994-09-13 | 1994-11-02 | Pfizer Ltd | Therapeutic agents |
| GB9419318D0 (en) * | 1994-09-24 | 1994-11-09 | Pfizer Ltd | Therapeutic agents |
-
1996
- 1996-08-12 MY MYPI96003300A patent/MY132385A/en unknown
- 1996-08-19 SI SI9630678T patent/SI0853617T1/xx unknown
- 1996-08-19 US US09/029,525 patent/US6080743A/en not_active Expired - Lifetime
- 1996-08-19 NZ NZ316497A patent/NZ316497A/xx unknown
- 1996-08-19 WO PCT/EP1996/003644 patent/WO1997008155A1/en not_active Application Discontinuation
- 1996-08-19 HU HU9801676A patent/HUP9801676A3/hu unknown
- 1996-08-19 ES ES96929275T patent/ES2217324T3/es not_active Expired - Lifetime
- 1996-08-19 CN CNB961965819A patent/CN1137886C/zh not_active Expired - Fee Related
- 1996-08-19 JP JP50980197A patent/JP3159711B2/ja not_active Expired - Fee Related
- 1996-08-19 SK SK252-98A patent/SK25298A3/sk unknown
- 1996-08-19 TR TR1998/00349T patent/TR199800349T2/xx unknown
- 1996-08-19 AU AU68742/96A patent/AU705871B2/en not_active Ceased
- 1996-08-19 PT PT96929275T patent/PT853617E/pt unknown
- 1996-08-19 IL IL12298796A patent/IL122987A/en not_active IP Right Cessation
- 1996-08-19 DK DK96929275T patent/DK0853617T3/da active
- 1996-08-19 KR KR10-1998-0701511A patent/KR100462337B1/ko not_active IP Right Cessation
- 1996-08-19 DE DE69631774T patent/DE69631774T2/de not_active Expired - Lifetime
- 1996-08-19 PL PL96324992A patent/PL189637B1/pl not_active IP Right Cessation
- 1996-08-19 CA CA002227851A patent/CA2227851C/en not_active Expired - Fee Related
- 1996-08-19 EP EP96929275A patent/EP0853617B1/en not_active Expired - Lifetime
- 1996-08-19 AT AT96929275T patent/ATE260902T1/de active
- 1996-08-19 CZ CZ98562A patent/CZ56298A3/cs unknown
- 1996-08-30 AR ARP960104160A patent/AR005229A1/es active IP Right Grant
- 1996-08-30 BR BRPI9603626A patent/BRPI9603626B8/pt not_active IP Right Cessation
-
1998
- 1998-02-26 NO NO19980814A patent/NO310236B1/no unknown
- 1998-10-16 HK HK98111287A patent/HK1010196A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0853617T3 (da) | 2,3-Dioxo-1,2,3,4-tetrahydro-quinoxalinylderivater | |
| DE59605821D1 (de) | l/4-SCALLABSORBER | |
| DE122009000076I1 (de) | Chinazolin-derivate | |
| FR2735198B1 (fr) | Piece d'accastillage de type manille-cosse | |
| ATE199150T1 (de) | Diphenylmethylenpiperidin-derivate | |
| BR9506532A (pt) | 1,2,3,4,-Tetraidro-5-Nitro-Pirimidinas substituidas | |
| BR9609884A (pt) | N-aril- 1,2,4-triazolin-5-onas | |
| DE69601527D1 (de) | Pyrrolylbenzimidazol-Derivate | |
| DE69618634D1 (de) | 1,4-benzodioxin-derivate | |
| ATA100695A (de) | Prothrombin-derivate | |
| ATE240307T1 (de) | Diarylalkenylamin-derivate | |
| NO961404D0 (no) | 4-indolylpiperazinyl-derivater | |
| NO960353D0 (no) | 4-aminobenzoylguanidinderivater | |
| ATE177102T1 (de) | Chromanderivate | |
| ATE220674T1 (de) | 12h-dibenzo(d,g)(1,3)dioxocin derivate | |
| ATE225347T1 (de) | Aza-anthracyclinone-derivate | |
| NO960392L (no) | 4-merkaptobenzoylguanidinderivater | |
| NO962931D0 (no) | N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat | |
| BR9510036A (pt) | Derivados de 1,3,4-oxadiazina | |
| BR9508248A (pt) | 1,2,4,6-Tiatriazinas herbicidas | |
| ATA45796A (de) | Lysin-prolin-derivate | |
| FR2735986B3 (fr) | Prolongateur d'haltere | |
| KR970009963U (ko) | 2축형 경첩 | |
| BR9610047A (pt) | 1,3,4-oxadiazolin-2-onas | |
| ZA967322B (en) | Novel 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives. |